Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.72 |
| ▸ | NPY4R | P50391 | 8/20 | 0.72 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.72 |
| ▸ | NPY1R | P25929 | 6/20 | 0.72 |
| ▸ | TFPI | P10646 | 5/20 | 0.62 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.61 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.61 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.61 |
| ▸ | KDM1A | O60341 | 2/20 | 0.61 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.60 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607416 | 0.93 | NPY2R (0.65) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29903370 | 0.93 | NPY2R (0.64) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30176436 | 0.91 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31182907 | 0.91 | NPY2R (0.66) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31182824 | 0.91 | NPY2R (0.72) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30537478 | 0.91 | NPY2R (0.70) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30437373 | 0.90 | MAPK8 (0.71) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL30176453 | 0.90 | NPY2R (0.64) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL9843196 | 0.90 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL9843188 | 0.90 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |